James Bramble - USANA Health Chief Legal Officer and Corporate Secretary
| USNA Stock | USD 43.46 0.51 1.16% |
Executive
Mr. James H. Bramble is Chief Legal Officer and Corporationrationrate Secretary of the Company. Mr. Bramble joined USANA in March 1998 to manage the Compliance and Legal Departments. In April 2006, he was appointed Vice President and General Counsel. In July 2008, Mr. Bramble was also appointed Corporationrationrate Secretary, and served in these roles until May 2011, when he was appointed Chief Legal Officer and Corporationrationrate Secretary. Prior to joining USANA, Mr. Bramble was employed with Novus Services since 2011.
| Age | 47 |
| Tenure | 13 years |
| Address | 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120 |
| Phone | 801 954 7100 |
| Web | https://www.usana.com |
USANA Health Management Efficiency
The company has return on total asset (ROA) of 0.0946 % which means that it generated a profit of $0.0946 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1369 %, meaning that it created $0.1369 on every $100 dollars invested by stockholders. USANA Health's management efficiency ratios could be used to measure how well USANA Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, USANA Health's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.25, whereas Return On Capital Employed is forecasted to decline to 0.26. At present, USANA Health's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 37.4 M, whereas Non Current Assets Total are forecasted to decline to about 110.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ken Elsbury | Central Garden Pet | N/A | |
| Joyce McCarthy | Central Garden Pet | 54 | |
| John Exner | Seneca Foods Corp | 62 | |
| George Yuhas | Central Garden Pet | 65 | |
| Howard Machek | Central Garden Pet | 61 | |
| William Pennington | Central Garden Pet | N/A | |
| Tony Murphy | Aryzta AG PK | 54 | |
| John Exner | Seneca Foods Corp | 62 | |
| Aron Kolosik | Central Garden Pet | N/A | |
| Mary Sagona | Seneca Foods Corp | N/A | |
| Michael Bridgford | Bridgford Foods | 42 | |
| Rhona OBrien | Aryzta AG PK | 43 | |
| George Yuhas | Central Garden Pet | 65 | |
| Erik Hansen | Coffee Holding Co | N/A | |
| Paul Meade | Aryzta AG PK | N/A | |
| Glen Axelrod | Central Garden Pet | N/A | |
| Lynwood Mallard | J J Snack | 55 | |
| Joyce McCarthy | Central Garden Pet | 54 | |
| John Heffernan | Aryzta AG PK | 47 | |
| Friederike Edelmann | Central Garden Pet | N/A | |
| Mary Kehoe | J J Snack | 62 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0946 |
USANA Health Sciences Leadership Team
Elected by the shareholders, the USANA Health's board of directors comprises two types of representatives: USANA Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of USANA. The board's role is to monitor USANA Health's management team and ensure that shareholders' interests are well served. USANA Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, USANA Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Wood, Independent Director | ||
| David Wentz, Co-CEO | ||
| G Iiekking, CFO | ||
| Andrew Masuda, Director Relations | ||
| Scott Nixon, Additional Independent Director | ||
| Patrique Richards, Executive Development | ||
| Donald Williams, Independent Director | ||
| Paul Jones, CFO, Principal Accounting Officer and Chief Leadership Devel. Officer | ||
| Peggie Pelosi, Independent Director | ||
| Frederic Winssinger, Independent Director | ||
| Joshua Foukas, General Officer | ||
| Jerry McClain, Independent Director | ||
| Douglas Hekking, Chief Officer | ||
| James Bramble, Chief Legal Officer and Corporate Secretary | ||
| John Cuomo, Executive Technology | ||
| Douglas Braun, Chief Marketing Officer | ||
| Walter Noot, Chief Operating Officer | ||
| Brian Dixon, Executive Education | ||
| Deborah Woo, President of Asia and Greater China | ||
| Richard Williams, Independent Director | ||
| P Foukas, Chief Legal Officer, General Counsel and Corporate Secretary | ||
| Ronald Poelman, Board Secretary, Independent Director | ||
| Donald Wiiliam, Independent Director | ||
| Josh Foukas, Executive Vice President - Legal | ||
| Feng Peng, Independent Director | ||
| Kevin Guest, Chairman of the Board, Chief Executive Officer | ||
| Xia Ding, Independent Director | ||
| Daniel Macuga, Chief Communications and Marketing Officer | ||
| Robert Anciaux, Independent Director | ||
| David Mulham, Chief Field Development Officer | ||
| Gilbert Fuller, Lead Independent Director | ||
| Myron Wentz, Founder and Chairman | ||
| John Fleming, Independent Director | ||
| Jim Brown, Chief Production Officer | ||
| Brent Neidig, Chief Officer and Managing Director of China | ||
| G Hekking, Chief Financial Officer | ||
| Robert Sinnott, Chief Scientific Officer | ||
| Robert Auciaux, Independent Director | ||
| Dr MNS, Chief Officer |
USANA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is USANA Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0946 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 528.79 M | ||||
| Shares Outstanding | 19.24 M | ||||
| Shares Owned By Insiders | 41.28 % | ||||
| Shares Owned By Institutions | 55.90 % | ||||
| Number Of Shares Shorted | 248.95 K | ||||
| Price To Earning | 8.70 X |
USANA Health Investors Sentiment
The influence of USANA Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in USANA. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to USANA Health's public news can be used to forecast risks associated with an investment in USANA. The trend in average sentiment can be used to explain how an investor holding USANA can time the market purely based on public headlines and social activities around USANA Health Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
USANA Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for USANA Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average USANA Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on USANA Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards USANA Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, USANA Health's short interest history, or implied volatility extrapolated from USANA Health options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for USANA Stock analysis
When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is USANA Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.32 | Earnings Share 3.3 | Revenue Per Share 47.845 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0946 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.